Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 1
2010 2
2011 1
2014 1
2017 1
2018 1
2020 1
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
The puzzling clinical presentation of fluoropyrimidines cardiotoxicity.
Cucciniello L, Bidoli E, Viel E, Canale ML, Gerratana L, Lestuzzi C. Cucciniello L, et al. Among authors: viel e. Front Cardiovasc Med. 2022 Sep 14;9:960240. doi: 10.3389/fcvm.2022.960240. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36186986 Free PMC article.
Cardiotoxicity from Capecitabine Chemotherapy: Prospective Study of Incidence at Rest and During Physical Exercise.
Lestuzzi C, Stolfo D, De Paoli A, Banzato A, Buonadonna A, Bidoli E, Tartuferi L, Viel E, De Angelis G, Lonardi S, Innocente R, Berretta M, Bergamo F, Guglielmi A, Sinagra G, Herrmann J. Lestuzzi C, et al. Among authors: viel e. Oncologist. 2022 Mar 4;27(2):e158-e167. doi: 10.1093/oncolo/oyab035. Oncologist. 2022. PMID: 35641220 Free PMC article.
Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi.
Luminari S, Viel E, Ferreri AJM, Zaja F, Chimienti E, Musuraca G, Tucci A, Balzarotti M, Tani M, Salvi F, Pesce EA, Ferrari A, Liberati AM, Spadea A, Marino D, Bruno-Ventre M, Volpetti S, Bottelli C, Ravaioli E, Merli F, Spina M. Luminari S, et al. Among authors: viel e. Hematol Oncol. 2018 Feb;36(1):68-75. doi: 10.1002/hon.2425. Epub 2017 May 19. Hematol Oncol. 2018. PMID: 28524259 Free article. Clinical Trial.
Anthracycline-free neoadjuvant therapy induces pathological complete responses by exploiting immune proficiency in HER2+ breast cancer patients.
Miolo G, Muraro E, Martorelli D, Lombardi D, Scalone S, Spazzapan S, Massarut S, Perin T, Viel E, Comaro E, Talamini R, Bidoli E, Turchet E, Crivellari D, Dolcetti R. Miolo G, et al. Among authors: viel e. BMC Cancer. 2014 Dec 15;14:954. doi: 10.1186/1471-2407-14-954. BMC Cancer. 2014. PMID: 25512030 Free PMC article. Clinical Trial.
Neoplastic pericardial disease in lung cancer: impact on outcomes of different treatment strategies. A multicenter study.
Lestuzzi C, Bearz A, Lafaras C, Gralec R, Cervesato E, Tomkowski W, DeBiasio M, Viel E, Bishiniotis T, Platogiannis DN, Buonadonna A, Tartuferi L, Piazza R, Tumolo S, Berretta M, Santini F, Imazio M. Lestuzzi C, et al. Among authors: viel e. Lung Cancer. 2011 Jun;72(3):340-7. doi: 10.1016/j.lungcan.2010.10.013. Epub 2010 Nov 30. Lung Cancer. 2011. PMID: 21122938